Â鶹ŮÓÅ

The results for nearly half of all clinical trials conducted by big drug makers during the last decade have not been published, and one company — Ranbaxy Laboratories — has not published findings for any of the nearly three dozen trials conducted in the past 10 years, according to a new online tool. The tool was launched Thursday by AllTrials, a consortium of researchers and medical journals that has been pushing the pharmaceutical industry to do a better job of disclosing clinical trial data. This is an important, but also contentious, issue because without access to such data, independent researchers are unable to verify results that can lead to improved treatments, better health care, and lower costs. (Silverman, 11/3)

The National Institutes of Health will require applicants for federal research funding to submit a plan outlining how data gleaned from a potential project will be shared with the public, Director Francis Collins told CQ Roll Call. This move is part of a larger push from President Barack Obama’s administration to make information gathered from government-backed studies more public. (Williams, 11/3)